Form C - Offering Statement:
SEC Accession No. 0001670254-24-000713
Filing Date
2024-06-21
Accepted
2024-06-20 20:04:40
Documents
11

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 11454
2 document_1.pdf EX-99 15716860
3 document_2.pdf EX-99 8442317
4 document_3.pdf EX-99 32471822
5 document_4.pdf EX-99 9871692
6 document_5.pdf EX-99 32474675
7 document_6.pdf EX-99 9874728
8 document_7.pdf EX-99 16987583
9 document_8.pdf EX-99 1091361
10 document_9.pdf EX-99 499667
11 documents_list.htm EX-99 123
  Complete submission text file 0001670254-24-000713.txt   172469390
Mailing Address 8022 SOUTHPARK CIRCLE SUITE 500 LITTLETON CO 80120
Business Address HIGH POINTE BUSINESS CENTER 8022 SOUTHPARK CIRCLE LITTLETON CO 80120 7206150515
AJNA BioSciences PBC (Filer) CIK: 0001900590 (see all company filings)

EIN.: 863415682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-34343 | Film No.: 241058078